Brief: Atomo Diagnostics Says Access Bio Receives FDA Clearance For Covid-19 Antibody Test
June 28 (Reuters) - Atomo Diagnostics Ltd AT1.AX :
* ACCESS BIO RECEIVES FDA CLEARANCE FOR COVID-19 ANTIBODY
TEST
* CO, ACCESS BIO ARE IN TALKS FOR THEIR COVID-19 RAPID TEST
COMMERCIAL ARRANGEMENTS
Source text for Eikon: ID:nASX7xQFsc
Further company coverage: AT1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Signs Agreement With Innovation Scientific
Brief: Atomo Diagnostics Ltd Appoints Cheri Walker As Interim Ceo
Brief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt